5-Methylmethiopropamine

Stimulant designer drugs
  • DE: NpSG (Industrial and scientific use only)
  • UK: Under Psychoactive Substances Act
Identifiers
  • N-methyl-1-(5-methylthiophen-2-yl)propan-2-amine
CAS Number
  • 1340105-79-4 checkY
PubChem CID
  • 64487873
ChemSpider
  • 46249721
UNII
  • ZP92FK3KK5
Chemical and physical dataFormulaC9H15NSMolar mass169.29 g·mol−13D model (JSmol)
  • Interactive image
  • CC1=CC=C(S1)CC(C)NC
InChI
  • InChI=1S/C9H15NS/c1-7(10-3)6-9-5-4-8(2)11-9/h4-5,7,10H,6H2,1-3H3
  • Key:HZICDJQMPRFRKC-UHFFFAOYSA-N

5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1][2][3]

See also

References

  1. ^ EU Early Warning System Situation Report. Situation report 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Report). 10 August 2020.
  2. ^ "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
  3. ^ New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020
  • v
  • t
  • e
AdamantanesAdenosine antagonistsAlkylaminesAmpakinesArylcyclohexylaminesBenzazepinesCathinonesCholinergicsConvulsantsEugeroicsOxazolinesPhenethylamines
PhenylmorpholinesPiperazinesPiperidinesPyrrolidinesRacetamsTropanesTryptaminesOthers